NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

表纸
市场调查报告书

成药的全球市场:各产品 (咳嗽、感冒&流感、止痛药,皮肤科产品、维生素和矿物质、补充品)、剂型、流通管道、地区的预测、机会 (2025年)

Global Over the Counter Drugs Market, By Product (Cough, Cold, and Flu, Analgesics, Dermatology Products, Vitamins, Mineral, and Supplements, Other), By Dosage Form, By Distribution Channel, By Region, Forecast & Opportunities, 2025

出版商 TechSci Research 商品编码 979721
出版日期 内容资讯 英文 112 Pages
商品交期: 请询问到货日
价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

成药的全球市场:各产品 (咳嗽、感冒&流感、止痛药,皮肤科产品、维生素和矿物质、补充品)、剂型、流通管道、地区的预测、机会 (2025年) Global Over the Counter Drugs Market, By Product (Cough, Cold, and Flu, Analgesics, Dermatology Products, Vitamins, Mineral, and Supplements, Other), By Dosage Form, By Distribution Channel, By Region, Forecast & Opportunities, 2025
出版日期: 2021年01月01日内容资讯: 英文 112 Pages
简介

全球成药的市场规模,2019年超过1400亿美元,预计在预测期间中约以8.23%的年复合成长率成长。全球成药市场,由于全球人们的健康意识高涨而受到推动。再加上OTC药的购买因为不用处方笺而成本效益高,预计给予在预测期间内的市场成长积极的影响。这些药的可得性和合理的价格,更加提高市场上的OTC药的采用率。还有急速扩大的医疗保健及医药品产业,预期今后数年更加强化市场成长。

本报告提供全球成药市场相关调查,各市场区隔为基础的分析与预测,市场趋势、竞争情形分析,并提供主要企业简介等资讯。

目录

第1章 产品概要

第2章 调查手法

第3章 COVID-19对全球成药市场的影响

第4章 摘要整理

第5章 客户的回响

第6章 全球成药市场展望

  • 市场规模与预测
    • 以金额为准
  • 市场占有率与预测
    • 各产品(咳嗽,感冒&流感,止痛药,皮肤科产品,维他命,矿物质,补充品(VMS),其他)
    • 各剂型(锭剂,胶囊,粉末,软膏,液体)
    • 各流通管道(医院药局,零售药局,线上药局,其他)
    • 各企业
    • 各地区
  • 产品市场地图

第7章 亚太地区的成药市场展望

  • 市场规模与预测
    • 以金额为准
  • 市场占有率与预测
    • 各产品
    • 各剂型
    • 各流通管道
    • 各国
  • 亚太地区:各国分析
    • 中国
    • 印度
    • 澳洲
    • 日本
    • 韩国

第8章 欧洲的成药市场展望

  • 市场规模与预测
    • 以金额为准
  • 市场占有率与预测
    • 各产品
    • 各剂型
    • 各流通管道
    • 各国
  • 欧洲:各国分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第9章 北美的成药市场展望

  • 市场规模与预测
    • 以金额为准
  • 市场占有率与预测
    • 各产品
    • 各剂型
    • 各流通管道
    • 各国
  • 北美:各国分析
    • 美国
    • 墨西哥
    • 加拿大

第10章 南美的成药市场展望

  • 市场规模与预测
    • 以金额为准
  • 市场占有率与预测
    • 各产品
    • 各剂型
    • 各流通管道
    • 各国
  • 南美:各国分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第11章 中东、非洲的成药市场展望

  • 市场规模与预测
    • 以金额为准
  • 市场占有率与预测
    • 各产品
    • 各剂型
    • 各流通管道
    • 各国
  • 中东、非洲:各国分析
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 科威特

第12章 市场动态

  • 促进因素
  • 课题

第13章 市场趋势

第14章 竞争情形

  • 竞争展望
  • 企业简介
  • 简介被做的主要企业
    • Johnson and Johnson
    • GlaxoSmithKline PLC (GSK Consumer Healthcare)
    • Perrigo Company PLC
    • Reckitt Benckiser Group PLC
    • Takeda Pharmaceutical Company Ltd
    • Roche Holding AG
    • The Procter & Gamble Company
    • Sanofi S.A
    • Gilead Sciences Inc.
    • Bayer Healthcare AG
    • AstraZeneca plc.
    • Alacer Corp.
    • Alcon Inc.

第15章 策略性推荐事项

第16章 关于本公司&免责声明

目录
Product Code: 5054

Title:
Global Over the Counter (OTC) Drugs Market, By Product (Cough, Cold, and Flu, Analgesics, Dermatology Products, Vitamins, Mineral, and Supplements (VMS), Other), By Dosage Form (Tablets, Capsules, Powders, Ointments, Liquids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Other), By Region, Forecast & Opportunities, 2025.

Global Over the Counter (OTC) drugs market exceeded USD 140 billion in 2019 and is expected to grow at a CAGR of around 8.23% during the forecast period. The global OTC drugs market is driven by rising health consciousness among the population across the globe. Moreover, buying OTC drugs is cost effective as they need no prescription, which is expected to positively impact the growth of market during the forecast period. The availability and affordability of these medicines has further increased the adoption rates of the OTC drugs in the market. Also, rapidly expanding healthcare and pharmaceuticals industries, is further expected to bolster the growth of market over the next few years.

The global over the counter (OTC) drugs market is segmented based on product, dosage form, distribution channel, company, and region. Based on product, the market can be categorized into cough, cold and flu products, analgesics, dermatology products, vitamins, mineral and supplements (VMS) and other. Out of these, the cough, cold, and flu products segment dominated the market in terms of largest market share until 2019 and is expected to maintain its leading position the market during the forecast period as well. This can be ascribed to growing number of infections which is leading to the rise in the number of infectious diseases. The market is further driven by the increasing efforts to licencing of OTC drugs for the treatment of cough, cold and flu. In addition to this, vitamins, mineral, and supplements (VMS) segment is expected to grow at a high pace in the next 5 years on account of the rising popularity of VMS products in developed countries because of the increasing diseased population. Based on the dosage form, the market is segmented into tablets, capsules, ointments, liquids, and powders. Out of these, tablets segment dominates the market and is expected to maintain its position. Tablets are usually preferred by the doctors and patients as it is the most convenient oral dosage form. Based on the distribution channel, the market can be segmented into retail pharmacies, hospital pharmacies, online pharmacy, and others. Out of these, retail pharmacies segment is the leading segment as, these are easily accessible. Furthermore, retail pharmacies have availability of a variety of drugs.

Major players operating in the global over the counter (OTC) drugs market include Johnson and Johnson, GlaxoSmithKline PLC (GSK Consumer Healthcare), Perrigo Company PLC, Reckitt Benckiser Group PLC, Takeda Pharmaceutical Company Ltd, Roche Holding AG, The Procter & Gamble Company, Sanofi S.A, Gilead Sciences Inc., Bayer Healthcare AG, AstraZeneca plc., Alacer Corp., Alcon Inc., and others. The companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnership, agreements, and new developments in order to expand their geographic reach and to increase their customer bases.

Years considered for this report:

  • Historical Years: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021-2025

Objective of the Study:

  • To analyze and estimate the market size of global over the counter (OTC) drugs market from 2015 to 2018.
  • To estimate and forecast the market size of global over the counter (OTC) drugs market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global over the counter (OTC) drugs market based on product, dosage form, distribution channel, company and regional distribution.
  • To identify dominant region or segment in the global over the counter (OTC) drugs market.
  • To identify drivers and challenges for global over the counter (OTC) drugs market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global over the counter (OTC) drugs market.
  • To conduct pricing analysis for global over the counter (OTC) drugs market.
  • To identify and analyze the profile of leading players operating in global over the counter (OTC) drugs market.
  • To identify key sustainable strategies adopted by market players in global over the counter (OTC) drugs market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the products and presence of all major players across the globe.

TechSci Research calculated the market size of global over the counter (OTC) drugs market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Over the counter (OTC) drugs manufacturers, suppliers and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to over the counter (OTC) drugs
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global over the counter (OTC) drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Over the Counter (OTC) Drugs Market, By Product:

Cough, Cold, and Flu, Analgesics

Dermatology Products

Vitamins, Mineral, and Supplements (VMS)

Other

  • Global Over the Counter (OTC) Drugs Market, By Dosage Form:

Tablets

Capsules

Powders

Ointments

Liquids

  • Global Over the Counter (OTC) Drugs Market, By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacy

Other

  • Global Over the Counter (OTC) Drugs Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global over the counter (OTC) drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Over the Counter (OTC) Drugs Market

4. Executive Summary

5. Voice of Customer

6. Global Over the Counter (OTC) Drugs Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Cough, Cold, and Flu, Analgesics, Dermatology Products, Vitamins, Mineral, and Supplements (VMS), Other)
    • 6.2.2. By Dosage Form (Tablets, Capsules, Powders, Ointments, Liquids)
    • 6.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Other)
    • 6.2.4. By Company (2019)
    • 6.2.5. By Region
  • 6.3. Product Market Map

7. Asia-Pacific Over the Counter (OTC) Drugs Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Dosage Form
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Over the Counter (OTC) Drugs Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Dosage Form
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. India Over the Counter (OTC) Drugs Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Dosage Form
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. Australia Over the Counter (OTC) Drugs Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Dosage Form
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. Japan Over the Counter (OTC) Drugs Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Dosage Form
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. South Korea Over the Counter (OTC) Drugs Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Dosage Form
        • 7.3.5.2.3. By Distribution Channel

8. Europe Over the Counter (OTC) Drugs Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Dosage Form
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Over the Counter (OTC) Drugs Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Dosage Form
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. Germany Over the Counter (OTC) Drugs Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Dosage Form
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. United Kingdom Over the Counter (OTC) Drugs Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Dosage Form
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. Italy Over the Counter (OTC) Drugs Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Dosage Form
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Spain Over the Counter (OTC) Drugs Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Dosage Form
        • 8.3.5.2.3. By Distribution Channel

9. North America Over the Counter (OTC) Drugs Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Dosage Form
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Over the Counter (OTC) Drugs Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Dosage Form
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. Mexico Over the Counter (OTC) Drugs Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Dosage Form
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. Canada Over the Counter (OTC) Drugs Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Dosage Form
        • 9.3.3.2.3. By Distribution Channel

10. South America Over the Counter (OTC) Drugs Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Dosage Form
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Over the Counter (OTC) Drugs Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Dosage Form
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Argentina Over the Counter (OTC) Drugs Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Dosage Form
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Colombia Over the Counter (OTC) Drugs Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Dosage Form
        • 10.3.3.2.3. By Distribution Channel

11. Middle East and Africa Over the Counter (OTC) Drugs Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Dosage Form
    • 11.2.3. By Distribution Channel
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Over the Counter (OTC) Drugs Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.2. By Dosage Form
        • 11.3.1.2.3. By Distribution Channel
    • 11.3.2. Saudi Arabia Over the Counter (OTC) Drugs Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.2. By Dosage Form
        • 11.3.2.2.3. By Distribution Channel
    • 11.3.3. UAE Over the Counter (OTC) Drugs Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.2. By Dosage Form
        • 11.3.3.2.3. By Distribution Channel
    • 11.3.4. Kuwait Over the Counter (OTC) Drugs Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Product
        • 11.3.4.2.2. By Dosage Form
        • 11.3.4.2.3. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Company Profiles
  • 14.3. Leading Players Profiled
    • 14.3.1. Johnson and Johnson
    • 14.3.2. GlaxoSmithKline PLC (GSK Consumer Healthcare)
    • 14.3.3. Perrigo Company PLC
    • 14.3.4. Reckitt Benckiser Group PLC
    • 14.3.5. Takeda Pharmaceutical Company Ltd
    • 14.3.6. Roche Holding AG
    • 14.3.7. The Procter & Gamble Company
    • 14.3.8. Sanofi S.A
    • 14.3.9. Gilead Sciences Inc.
    • 14.3.10. Bayer Healthcare AG
    • 14.3.11. AstraZeneca plc.
    • 14.3.12. Alacer Corp.
    • 14.3.13. Alcon Inc.

15. Strategic Recommendations

16. About Us & Disclaimer

List of Figures

  • Figure 1: Global OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 2: Global OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 3: Global OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 4: Global OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 5: Global OTC Drugs Market Size, By Company (USD Million), 2015-2025F
  • Figure 6: Global OTC Drugs Market Size, By Region (USD Million), 2015-2025F
  • Figure 7: Global OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 8: North America OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 9: North America OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 10: North America OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 11: North America OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 12: North America OTC Drugs Market Size, By Country (USD Million), 2015-2025F
  • Figure 13: North America OTC Drugs Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 14: North America OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 15: United States OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 16: United States OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 17: United States OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 18: United States OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 19: United States OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 20: Canada OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 21: Canada OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 22: Canada OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 23: Canada OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 24: Canada OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 25: Mexico OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 26: Mexico OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 27: Mexico OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 28: Mexico OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 29: Mexico OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 30: Europe OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 31: Europe OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 32: Europe OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 33: Europe OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 34: Europe OTC Drugs Market Size, By Country (USD Million), 2015-2025F
  • Figure 35: Europe OTC Drugs Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 36: Europe OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 37: France OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 38: France OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 39: France OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 40: France OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 41: France OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 42: Germany OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 43: Germany OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 44: Germany OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 45: Germany OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 46: Germany OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 47: Italy OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 48: Italy OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 49: Italy OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 50: Italy OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 51: Italy OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 52: Spain OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 53: Spain OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 54: Spain OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 55: Spain OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 56: Spain OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 57: United Kingdom OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 58: United Kingdom OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 59: United Kingdom OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 60: United Kingdom OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 61: United Kingdom OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 62: Asia-Pacific OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 63: Asia-Pacific OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 64: Asia-Pacific OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 65: Asia-Pacific OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 66: Asia-Pacific OTC Drugs Market Size, By Country (USD Million), 2015-2025F
  • Figure 67: Asia-Pacific OTC Drugs Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 68: Asia-Pacific OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 69: China OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 70: China OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 71: China OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 72: China OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 73: China OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 74: India OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 75: India OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 76: India OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 77: India OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 78: India OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 79: Japan OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 80: Japan OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 81: Japan OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 82: Japan OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 83: Japan OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 84: South Korea OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 85: South Korea OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 86: South Korea OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 87: South Korea OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 88: South Korea OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 89: Australia OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 90: Australia OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 91: Australia OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 92: Australia OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 93: Australia OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 94: Middle East and Africa OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 95: Middle East and Africa OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 96: Middle East and Africa OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 97: Middle East and Africa OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 98: Middle East and Africa OTC Drugs Market Size, By Country (USD Million), 2015-2025F
  • Figure 99: Middle East and Africa OTC Drugs Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 100: Middle East and Africa OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 101: South Africa OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 102: South Africa OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 103: South Africa OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 104: South Africa OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 105: South Africa OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 106: Saudi Arabia OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 107: Saudi Arabia OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 108: Saudi Arabia OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 109: Saudi Arabia OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 110: Saudi Arabia OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 111: Kuwait OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 112: Kuwait OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 113: Kuwait OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 114: Kuwait OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 115: Kuwait OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 116: UAE OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 117: UAE OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 118: UAE OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 119: UAE OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 120: UAE OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 121: South America OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 122: South America OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 123: South America OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 124: South America OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 125: South America OTC Drugs Market Size, By Country (USD Million), 2015-2025F
  • Figure 126: South America OTC Drugs Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 127: South America OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 128: Brazil OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 129: Brazil OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 130: Brazil OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 131: Brazil OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 132: Brazil OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 133: Argentina OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 134: Argentina OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 135: Argentina OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 136: Argentina OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 137: Argentina OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 138: Colombia OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 139: Colombia OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 140: Colombia OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 141: Colombia OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 142: Colombia OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F